Clinical Trials Details

Brain Cancer

A Randomized, Phase III, Double-Blind, Placebo-Controlled Trial Of Memantine For Prevention Of Cognitive Dysfunction In Patients Receiving Whole-Brain Radiotherapy

Trial ID: 08182

Contact: Denise L Elmore

Phone: (281)863-4609

Learn More about this trial.

go back | new search

This Study is currently being offered at the following Sites:

Practice	State/City
New York Oncology Hematology, P.C.	Albany, NY (Patroon)
Texas Oncology, P.A.	Arlington, TX (South)
Rocky Mountain Cancer Centers, LLP	Aurora, CO
Texas Oncology, P.A.	Bedford, TX (Edwards CC)(RAD)
Texas Oncology, P.A.	Fort Worth, TX (12th Ave.)
Texas Oncology, P.A.	Fort Worth, TX (8th) Rad Only
Texas Oncology, P.A.	Fort Worth, TX (Klabzuba) Rad
Central Indiana Cancer Centers	Indianapolis, IN (E. County)
Kansas City Cancer Center, LLC.	Kansas City, MO (North)
Texas Oncology, P.A.	Longview, TX
Texas Oncology, P.A.	Odessa, TX
Cancer Centers of Florida, P.A.	Orlando, FL (52 Gore) RT ONLY
Kansas City Cancer Center, LLC.	Overland Park, KS (CBO)
Texas Oncology, P.A.	Sherman, TX
Cancer Care Northwest, P.S.	Spokane, WA (Sherman)
Texas Oncology, P.A.	Sugar Land, TX
Arizona Oncology Associates, PC - SRO	Tucson, AZ (Orange Grove Rd)